报告期内，公司以智能体、智能化平台及数据资源为核心，推动基因检测技术与人工智能算法深度融 合，助力精准医疗领域创新发展，带动和产生了一定收入。新生儿基因筛查业务按预期顺利推动，预计 后续对公司在生育健康领域的业务布局产生较大的积极影响。 格隆汇1月30日丨贝瑞基因(000710.SZ)发布2025年度业绩预告，报告期内，归属于上市公司股东的净利 润为亏损1.70亿元—2.50亿元，上年同期亏损1.92亿元；扣除非经常性损益后的净利润为亏损1.65亿元— 2.45亿元，上年同期亏损1.92亿元。 报告期内，受生育下降等因素影响，公司营业收入有所下滑，经营性现金流保持平稳水平。根据会计准 则要求，公司基于谨慎性原则对各类资产进行全面检查和减值测试，谨慎计提各项资产减值，对报告期 净利润产生了一定影响。报告期内，公司持续加大研发投入、积极开拓产品线，三代基因测序的技术水 平和市场能力进一步提升，研发费用的阶段性较高投入对公司当期净利润造成了一定影响。 ...

Group 1 - Tianhua New Energy announced that CATL plans to acquire 12.95% of the company's shares, totaling 1.08 billion shares at a price of 24.49 yuan per share, amounting to 2.635 billion yuan [2] - Zhenyu Technology plans to invest 2.11 billion yuan in the production of humanoid robot precision modules and components, in collaboration with Ninghai County [2] - Tianqi Co., Ltd. signed a strategic cooperation framework agreement with Foxconn to deploy at least 2,000 embodied intelligent robots in the next five years [2] Group 2 - Qingyue Technology is under investigation by the China Securities Regulatory Commission for suspected false financial reporting [3] - Bestme's actual controller is being investigated for failing to fulfill mandatory tender offer obligations and information disclosure violations [4] Group 3 - Inno Group announced the termination of a major asset restructuring plan to acquire 80% of Zhizhe Tongxing Brand Management Consulting [6] - Weigao Blood Purification plans to acquire 100% of Weigao Purui Pharmaceutical Packaging, with stock resuming trading on November 3 [7] - Zhongyuan Co., Ltd. is undergoing a change in actual control, with stock resuming trading on November 3 [8] Group 4 - China General Nuclear Power has completed the payment for the acquisition of shares in Huizhou Nuclear Power and three other companies [9] - Baichuan Energy plans to acquire 22.86% of Xi'an Zhongke Optoelectronics for 215 million yuan [9] - Lan科高新 has changed its major asset restructuring plan to acquire 51% of China Air Separation [9]

Company Highlights - Tianqi Co., Ltd. signed a strategic cooperation framework agreement with Foxconn Automotive, planning to deploy no less than 2,000 embodied intelligent robots in the next five years [1] - Tianhua New Energy's actual controllers plan to transfer 12.95% of shares to CATL at a price of 24.49 yuan per share, which is a 19% discount compared to the closing price [2] - Zhenyu Technology plans to invest 21.1 billion yuan in humanoid robot precision module and component projects [3] - Taiyuan Heavy Industry disclosed false financial data in its annual report, leading to a change in its stock name to "ST Tai Heavy" starting November 4 [4] Investment & Contracts - East Asia Machinery plans to invest 400 million yuan to build an intelligent manufacturing base for air compressors and core components in Central China [12] Shareholding Changes - TuoStar's director plans to reduce his holdings by up to 0.95% [14] - Shanghai Fosun Pharmaceutical plans to reduce its holdings in Shanhe Pharmaceutical by up to 3% [16] Business Performance - Pingzhi Information reported a total procurement amount of 469 million yuan for server-related products since May [17] - Berry Genomics received medical device registration for the world's first clinically approved third-generation sequencing platform, Sequel® IICNDx [18] Contracts & Project Awards - Hopu Co., Ltd. signed a 5.2 billion yuan procurement contract for a storage system [20] - Qiaoyin Co., Ltd. received a bid notification for a 5.12 billion yuan urban sanitation integration project [20] Stock Price Movements - Hezhong China experienced a 46.56% increase in stock price over four consecutive trading days, indicating potential irrational speculation [22] Other Announcements - Huaxin Cement will change its stock name to Huaxin Building Materials starting November 6 [23]